Hypertension and Alzheimer's disease;L'hypertension artérielle est-elle associée à la maladie d'Alzheimer?

Presse Medicale

Volumn 34, Issue 11, 2005, Pages 809-812

  Vogel, Thomas ^a   Verreault, René ^b   Kaltenbach, Georges ^a   Berthel, Marc ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE COURSE; FOLLOW UP; HUMAN; HYPERTENSION; HYPOTENSION; LONG TERM CARE; PATHOGENESIS; PROPHYLAXIS; REVIEW; RISK FACTOR;

EID: 21644484039     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)84049-7     Document Type: Review

References (20)

1. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 1996; 312: 805-8.
2. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001; 58: 1640-6.
3. Posner H B, Tang M-X, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002; 5B: 1175-81.
4. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156: 445-53.
5. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001; 322: 1447-51.
6. Launer U, Ross GW, Petrovitch H, Masaki K, Foley D, White LR et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000; 21: 49-55.
7. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging 2000; 21: 57-62.
8. Qiu C, Winblad B, Viitanen M, Fratiglioni L. Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. Stroke 2003; 34: 594-9.
9. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 1996; 312: 801-5.
10. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 1994; 154: 2154-60.
11. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-51.
12. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S et al. Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002; 162: 2046-52.
13. In't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001; 22: 407-12.
14. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069-75.
15. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B et al. SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertension 2004; 22: 1605-12.
16. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; Suppl 3: S115-23.
17. Skoog I, Kalaria RN, Breteler MM. Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 1999; Suppl 3: S106-14.
18. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277: 813-17.
19. Qiu C, Winblad B, Fastbom J, Fratiglioni L. Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. Neurology 2003; 61: 655-60.
20. De la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann N Y Acad Sci 2002; 977: 196-215.